Find Research Outputs

Search in all content

Filters for Scholarly Output

Search concepts
Selected Filters

Publication Year

  • 2020
  • 2019
  • 2018
  • 2017
  • 2016

Author

  • Jorge Eduardo Cortes
2017

Phase II trial of homoharringtonine with imatinib in chronic, accelerated, and blast phase chronic myeloid leukemia

Maiti, A., Cortes, J., Ferrajoli, A., Estrov, Z., Borthakur, G., Garcia-Manero, G., Jabbour, E., Ravandi, F., O’Brien, S. & Kantarjian, H., Sep 2 2017, In : Leukemia and Lymphoma. 58, 9, p. 2240-2242 3 p.

Research output: Contribution to journalLetter

3 Scopus citations
2018

Ponatinib efficacy and safety in Philadelphia chromosome–positive leukemia: final 5-year results of the phase 2 PACE trial

Cortes, J. E., Kim, D. W., Pinilla-Ibarz, J., le Coutre, P. D., Paquette, R., Chuah, C., Nicolini, F. E., Apperley, J. F., Khoury, H. J., Talpaz, M., DeAngelo, D. J., Abruzzese, E., Rea, D., Baccarani, M., Müller, M. C., Gambacorti-Passerini, C., Lustgarten, S., Rivera, V. M., Haluska, F. G., Guilhot, F. & 5 others, Deininger, M. W., Hochhaus, A., Hughes, T. P., Shah, N. P. & Kantarjian, H. M., Jul 26 2018, In : Blood. 132, 4, p. 393-404 12 p.

Research output: Contribution to journalArticle

Open Access
83 Scopus citations
2020

Ultra-accurate Duplex Sequencing for the assessment of pretreatment ABL1 kinase domain mutations in Ph+ ALL

Short, N. J., Kantarjian, H., Kanagal-Shamanna, R., Sasaki, K., Ravandi, F., Cortes, J., Konopleva, M., Issa, G. C., Kornblau, S. M., Garcia-Manero, G., Garris, R., Higgins, J., Pratt, G., Williams, L. N., Valentine, C. C., Rivera, V. M., Pritchard, J., Salk, J. J., Radich, J. & Jabbour, E., May 1 2020, In : Blood Cancer Journal. 10, 5, 61.

Research output: Contribution to journalArticle

Open Access
2019

Population Pharmacokinetics of Glasdegib in Patients With Advanced Hematologic Malignancies and Solid Tumors

Lin, S., Shaik, N., Martinelli, G., Wagner, A. J., Cortes, J. & Ruiz-Garcia, A., 2019, (Accepted/In press) In : Journal of Clinical Pharmacology.

Research output: Contribution to journalArticle

Open Access
1 Scopus citations
2017

Clinical use of ruxolitinib in an academic medical center in unselected patients with myeloproliferative neoplasms not on clinical study

Naqvi, K., Daver, N., Pemmaraju, N., Bose, P., Garcia-Manero, G., Cortes, J., Kantarjian, H. M. & Verstovsek, S., Apr 3 2017, In : Leukemia and Lymphoma. 58, 4, p. 866-871 6 p.

Research output: Contribution to journalArticle

3 Scopus citations
2016

Omacetaxine Mepesuccinate for Chronic Myeloid Leukemia

Rosshandler, Y., Shen, A. Q., Cortes, J. & Khoury, H. J., May 3 2016, In : Expert Review of Hematology. 9, 5, p. 419-424 6 p.

Research output: Contribution to journalReview article

10 Scopus citations
2020

Phase 1 study of CWP232291 in patients with relapsed or refractory acute myeloid leukemia and myelodysplastic syndrome

Lee, J. H., Faderl, S., Pagel, J. M., Jung, C. W., Yoon, S. S., Pardanani, A. D., Becker, P. S., Lee, H., Choi, J., Lee, K., Kim, M. & Cortes, J. E., May 12 2020, In : Blood Advances. 4, 9, p. 2032-2043 12 p.

Research output: Contribution to journalArticle

Open Access
2016

Compound mutations in BCR-ABL1 are not major drivers of primary or secondary resistance to ponatinib in CP-CML patients

Deininger, M. W., Hodgson, J. G., Shah, N. P., Cortes, J. E., Kim, D. W., Nicolini, F. E., Talpaz, M., Baccarani, M., Müller, M. C., Li, J., Parker, W. T., Lustgarten, S., Clackson, T., Haluska, F. G., Guilhot, F., Kantarjian, H. M., Soverini, S., Hochhaus, A., Hughes, T. P., Rivera, V. M. & 1 others, Branford, S., Feb 11 2016, In : Blood. 127, 6, p. 703-712 10 p.

Research output: Contribution to journalArticle

Open Access
57 Scopus citations
2018

The absolute percent deviation of IGHV mutation rather than a 98% cut-off predicts survival of chronic lymphocytic leukaemia patients treated with fludarabine, cyclophosphamide and rituximab

Jain, P., Nogueras González, G. M., Kanagal-Shamanna, R., Rozovski, U., Sarwari, N., Tam, C., Wierda, W. G., Thompson, P. A., Jain, N., Luthra, R., Quesada, A., Sanchez-Petitto, G., Ferrajoli, A., Burger, J., Kantarjian, H., Cortes, J., O'Brien, S., Keating, M. J. & Estrov, Z., Jan 2018, In : British Journal of Haematology. 180, 1, p. 33-40 8 p.

Research output: Contribution to journalArticle

Open Access
16 Scopus citations
2019

Validation of the 2017 European LeukemiaNet classification for acute myeloid leukemia with NPM1 and FLT3-internal tandem duplication genotypes

Boddu, P. C., Kadia, T. M., Garcia-Manero, G., Cortes, J., Alfayez, M., Borthakur, G., Konopleva, M., Jabbour, E. J., Daver, N. G., DiNardo, C. D., Naqvi, K., Yilmaz, M., Short, N. J., Pierce, S., Kantarjian, H. M. & Ravandi, F., Apr 1 2019, In : Cancer. 125, 7, p. 1091-1100 10 p.

Research output: Contribution to journalArticle

13 Scopus citations
2018

Recent advances in the genomics and therapy of BCR/ABL1-positive and -negative chronic myeloproliferative neoplasms

Mughal, T. I., Gotlib, J., Mesa, R., Koschmieder, S., Khoury, H. J., Cortes, J. E., Barbui, T., Hehlmann, R., Mauro, M., Saussele, S., Radich, J. P., Van Etten, R. A., Saglio, G., Verstovek, S., Gale, R. P. & Abdel-Wahab, O., Apr 2018, In : Leukemia Research. 67, p. 67-74 8 p.

Research output: Contribution to journalReview article

4 Scopus citations
2019

Idarubicin, cytarabine, and nivolumab in patients with newly diagnosed acute myeloid leukaemia or high-risk myelodysplastic syndrome: a single-arm, phase 2 study

Ravandi, F., Assi, R., Daver, N., Benton, C. B., Kadia, T., Thompson, P. A., Borthakur, G., Alvarado, Y., Jabbour, E. J., Konopleva, M., Takahashi, K., Kornblau, S., DiNardo, C. D., Estrov, Z., Flores, W., Basu, S., Allison, J., Sharma, P., Pierce, S., Pike, A. & 3 others, Cortes, J. E., Garcia-Manero, G. & Kantarjian, H. M., Sep 2019, In : The Lancet Haematology. 6, 9, p. e480-e488

Research output: Contribution to journalArticle

8 Scopus citations
2020

Efficacy of ruxolitinib in patients with chronic neutrophilic leukemia and atypical chronic myeloid leukemia

Dao, K. H. T., Gotlib, J., Deininger, M. M. N., Oh, S. T., Cortes, J. E., Collins, R. H., Winton, E. F., Parker, D. R., Lee, H., Schultz, A. R., Stevens, S. S., Brockett, C., Subbiah, N., Press, R. D., Raess, P. W., Cascio, M., Dunlap, J., Chen, Y., Degnin, C., Maxson, J. E. & 4 others, Tognon, C. E., Macey, T., Druker, B. J. & Tyner, J. W., Apr 1 2020, In : Journal of Clinical Oncology. 38, 10, p. 1006-1018 13 p.

Research output: Contribution to journalArticle

2 Scopus citations
2016

Clofarabine Plus Low-Dose Cytarabine Is as Effective as and Less Toxic Than Intensive Chemotherapy in Elderly AML Patients

Takahashi, K., Kantarjian, H., Garcia-Manero, G., Borthakur, G., Kadia, T., Dinardo, C., Jabbour, E., Pierce, S., Estrov, Z., Konopleva, M., Andreeff, M., Ravandi, F. & Cortes, J., Mar 1 2016, In : Clinical Lymphoma, Myeloma and Leukemia. 16, 3, p. 163-168.e2

Research output: Contribution to journalArticle

10 Scopus citations
2018

Early results of lower dose dasatinib (50 mg daily) as frontline therapy for newly diagnosed chronic-phase chronic myeloid leukemia

Naqvi, K., Jabbour, E., Skinner, J., Yilmaz, M., Ferrajoli, A., Bose, P., Thompson, P., Alvarado, Y., Jain, N., Takahashi, K., Burger, J., Estrov, Z., Borthakur, G., Pemmaraju, N., Paul, S., Cortes, J. & Kantarjian, H. M., Jul 1 2018, In : Cancer. 124, 13, p. 2740-2747 8 p.

Research output: Contribution to journalArticle

19 Scopus citations
2017

Combined inhibition of β-catenin and Bcr–Abl synergistically targets tyrosine kinase inhibitor-resistant blast crisis chronic myeloid leukemia blasts and progenitors in vitro and in vivo

Zhou, H., Mak, P. Y., Mu, H., Mak, D. H., Zeng, Z., Cortes, J., Liu, Q., Andreeff, M. & Carter, B. Z., Apr 18 2017, (Accepted/In press) In : Leukemia.

Research output: Contribution to journalArticle

37 Scopus citations
2019

Sorafenib plus intensive chemotherapy improves survival in patients with newly diagnosed, FLT3-internal tandem duplication mutation–positive acute myeloid leukemia

Sasaki, K., Kantarjian, H. M., Kadia, T., Patel, K., Loghavi, S., Garcia-Manero, G., Jabbour, E. J., DiNardo, C., Pemmaraju, N., Daver, N., Dalle, I. A., Short, N., Yilmaz, M., Bose, P., Naqvi, K., Pierce, S., Yalniz, F., Cortes, J. E. & Ravandi, F., Nov 1 2019, In : Cancer. 125, 21, p. 3755-3766 12 p.

Research output: Contribution to journalArticle

6 Scopus citations
2020

Phase 2 study of hyper-CMAD with liposomal vincristine for patients with newly diagnosed acute lymphoblastic leukemia

Sasaki, K., Kantarjian, H., Wierda, W., Ravandi-Kashani, F., Jorgensen, J., Wang, S. A., Khoury, J., Daver, N., Burger, J., Di Nardo, C. D., Jain, N., Short, N. J., Estrov MD, Z., Konopleva MD, PhD, M., Ohanian DO, M., Garcia-Manero, G., Kadia, T., Alvarado-Valero, Y., Yilmaz, M., Pierce, S. & 5 others, Garris, R., Ingram, A., Cortes, J., OʼBrien, S. & Jabbour, E., Jul 1 2020, In : American Journal of Hematology. 95, 7, p. 734-739 6 p.

Research output: Contribution to journalArticle

2019

Genetic Characteristics and Outcomes By Mutation Status in a Phase 3 Study of CPX-351 Versus 7+3 in Older Adults with Newly Diagnosed, High-Risk/Secondary Acute Myeloid Leukemia (AML)

Lindsley, R. C., Gibson, C. J., Murdock, H. M., Stone, R. M., Cortes, J. E., Uy, G. L., Lin, T. L., Ritchie, E. K., Prebet, T., Ryan, R. J., Faderl, S. & Lancet, J. E., Nov 13 2019, In : Blood. 134, 1, 1 p.

Research output: Contribution to journalArticle

2020

Venetoclax and BCR-ABL Tyrosine Kinase Inhibitor Combinations: Outcome in Patients with Philadelphia Chromosome-Positive Advanced Myeloid Leukemias

Maiti, A., Franquiz, M. J., Ravandi, F., Cortes, J. E., Jabbour, E. J., Sasaki, K., Marx, K., Daver, N. G., Kadia, T. M., Konopleva, M. Y., Masarova, L., Borthakur, G., Dinardo, C. D., Naqvi, K., Pierce, S., Kantarjian, H. M. & Short, N. J., 2020, (Accepted/In press) In : Acta Haematologica.

Research output: Contribution to journalArticle

1 Scopus citations
2019

Neurotoxic events associated with BCR-ABL1 tyrosine kinase inhibitors: a case series

Rafei, H., Jabbour, E. J., Kantarjian, H., Sinicrope, K. D., Kamiya-Matsuoka, C., Mehta, R. S., Daver, N. G., Kadia, T. M., Naqvi, K., Cortes, J. & Konopleva, M., Nov 10 2019, In : Leukemia and Lymphoma. 60, 13, p. 3292-3295 4 p.

Research output: Contribution to journalLetter

2020

The Clinical impact of PTPN11 mutations in adults with acute myeloid leukemia

Alfayez, M., Issa, G. C., Patel, K. P., Wang, F., Wang, X., Short, N. J., Cortes, J. E., Kadia, T., Ravandi, F., Pierce, S., Assi, R., Garcia-Manero, G., DiNardo, C. D., Daver, N., Pemmaraju, N., Kantarjian, H. & Borthakur, G., 2020, (Accepted/In press) In : Leukemia.

Research output: Contribution to journalArticle

2018

Addition of eltrombopag to immunosuppressive therapy in patients with newly diagnosed aplastic anemia

Assi, R., Garcia-Manero, G., Ravandi, F., Borthakur, G., Daver, N. G., Jabbour, E., Burger, J., Estrov, Z., Dinardo, C. D., Alvarado, Y., Hendrickson, S., Ferrajoli, A., Wierda, W., Cortes, J., Kantarjian, H. & Kadia, T. M., Nov 1 2018, In : Cancer. 124, 21, p. 4192-4201 10 p.

Research output: Contribution to journalArticle

Open Access
5 Scopus citations
2019

Sudden blastic transformation in treatment-free remission chronic myeloid leukaemia

Alfayez, M., Richard-Carpentier, G., Jabbour, E., Vishnu, P., Naqvi, K., Sasaki, K., Cortes, J. & Pemmaraju, N., Nov 1 2019, In : British Journal of Haematology. 187, 4, p. 543-545 3 p.

Research output: Contribution to journalLetter

Open Access
3 Scopus citations
2017

First-line treatment selection and early monitoring patterns in chronic phase-chronic myeloid leukemia in routine clinical practice: SIMPLICITY

Goldberg, S. L., Cortes, J. E., Gambacorti-Passerini, C., Hehlmann, R., Khoury, H. J., Michallet, M., Paquette, R. L., Simonsson, B., Zyczynski, T., Foreman, A., Abruzzese, E., Andorsky, D., Beeker, A., Cony-Makhoul, P., Hansen, R., Lomaia, E., Olavarria, E. & Mauro, M. J., Nov 2017, In : American Journal of Hematology. 92, 11, p. 1214-1223 10 p.

Research output: Contribution to journalArticle

Open Access
17 Scopus citations
2016

Outcome of Patients With Therapy-Related Acute Myeloid Leukemia With or Without a History of Myelodysplasia

Sasaki, K., Jabbour, E., Cortes, J., Kadia, T., Garcia-Manero, G., Borthakur, G., Jain, P., Pierce, S., Daver, N., Takahashi, K., O'Brien, S., Kantarjian, H. & Ravandi, F., Nov 1 2016, In : Clinical Lymphoma, Myeloma and Leukemia. 16, 11, p. 616-624 9 p.

Research output: Contribution to journalArticle

8 Scopus citations
2020

Consolidation outcomes in CPX-351 versus cytarabine/daunorubicin-treated older patients with high-risk/secondary acute myeloid leukemia

Kolitz, J. E., Strickland, S. A., Cortes, J. E., Hogge, D., Lancet, J. E., Goldberg, S. L., Villa, K. F., Ryan, R. J., Chiarella, M., Louie, A. C., Ritchie, E. K. & Stuart, R. K., Feb 23 2020, In : Leukemia and Lymphoma. 61, 3, p. 631-640 10 p.

Research output: Contribution to journalArticle

Open Access
1 Scopus citations
2019

Philadelphia chromosome-positive acute lymphoblastic leukemia at first relapse in the era of tyrosine kinase inhibitors

Abou Dalle, I., Kantarjian, H. M., Short, N. J., Konopleva, M., Jain, N., Garcia-Manero, G., Garris, R., Qiao, W., Cortes, J. E., O'Brien, S., Kebriaei, P., Kadia, T., Jabbour, E. & Ravandi, F., Dec 2019, In : American Journal of Hematology. 94, 12, p. 1388-1395 8 p.

Research output: Contribution to journalArticle

1 Scopus citations
2016

Evaluating the Impact of a Switch to Nilotinib on Imatinib-Related Chronic Low-Grade Adverse Events in Patients with CML-CP: The ENRICH Study

Cortes, J. E., Lipton, J. H., Miller, C. B., Busque, L., Akard, L. P., Pinilla-Ibarz, J., Keir, C., Warsi, G., Lin, F. P. & Mauro, M. J., May 1 2016, In : Clinical Lymphoma, Myeloma and Leukemia. 16, 5, p. 286-296 11 p.

Research output: Contribution to journalArticle

Open Access
19 Scopus citations
2017

Corrigendum to “KB004, a first in class monoclonal antibody targeting the receptor tyrosine kinase EphA3, in patients with advanced hematologic malignancies: Results from a phase 1 study” [Leuk. Res. 50 (Nov) (2016) 123–131. PubMed PMID: 27736729](S0145212616301989)(10.1016/j.leukres.2016.09.012)

Swords, R. T., Greenberg, P. L., Wei, A. H., Durrant, S., Advani, A. S., Hertzberg, M. S., Lewis, I. D., Rivera, G., Gratzinger, D., Fan, A. C., Felsher, D. W., Cortes, J. E., Watts, J. M., Yarranton, G. T., Walling, J. M. & Lancet, J. E., Aug 2017, In : Leukemia Research. 59, 1 p.

Research output: Contribution to journalComment/debate

Open Access
2016

Early T-cell precursor acute lymphoblastic leukemia/lymphoma (ETP-ALL/LBL) in adolescents and adults: A high-risk subtype

Jain, N., Lamb, A. V., O'Brien, S., Ravandi, F., Konopleva, M., Jabbour, E., Zuo, Z., Jorgensen, J., Lin, P., Pierce, S., Thomas, D., Rytting, M., Borthakur, G., Kadia, T., Cortes, J., Kantarjian, H. M. & Khoury, J. D., Apr 14 2016, In : Blood. 127, 15, p. 1863-1869 7 p.

Research output: Contribution to journalArticle

Open Access
99 Scopus citations

Multiparameter Analysis of Off-Target Effects of Dasatinib on Bone Homeostasis in Patients With Newly Diagnosed Chronic Myelogenous Leukemia

Hoehn, D., Cortes, J. E., Medeiros, L. J., Jabbour, E. J., Hidalgo, J. E., Kanagal-Shamanna, R. & Bueso-Ramos, C. E., Aug 1 2016, In : Clinical Lymphoma, Myeloma and Leukemia. 16, p. S86-S92

Research output: Contribution to journalArticle

1 Scopus citations
2017

Persistence of minimal residual disease assessed by multiparameter flow cytometry is highly prognostic in younger patients with acute myeloid leukemia

Ravandi, F., Jorgensen, J., Borthakur, G., Jabbour, E., Kadia, T., Pierce, S., Brandt, M., Wang, S., Konoplev, S., Wang, X., Huang, X., Daver, N., DiNardo, C., Andreeff, M., Konopleva, M., Estrov, Z., Garcia-Manero, G., Cortes, J. & Kantarjian, H., Feb 1 2017, In : Cancer. 123, 3, p. 426-435 10 p.

Research output: Contribution to journalArticle

Open Access
30 Scopus citations

A clinical trial for patients with acute myeloid leukemia or myelodysplastic syndromes not eligible for standard clinical trials

Montalban-Bravo, G., Huang, X., Jabbour, E., Borthakur, G., DiNardo, C. D., Pemmaraju, N., Cortes, J., Verstovsek, S., Kadia, T., Daver, N., Wierda, W., Alvarado, Y., Konopleva, M., Ravandi, F., Estrov, Z., Jain, N., Alfonso, A., Brandt, M., Sneed, T., Chen, H. C. & 7 others, Yang, H., Bueso-Ramos, C., Pierce, S., Estey, E., Bohannan, Z., Kantarjian, H. M. & Garcia-Manero, G., Feb 1 2017, In : Leukemia. 31, 2, p. 318-324 7 p.

Research output: Contribution to journalArticle

14 Scopus citations

Clonal chromosomal abnormalities appearing in Philadelphia chromosome–negative metaphases during CML treatment

Issa, G. C., Kantarjian, H. M., Gonzalez, G. N., Borthakur, G., Tang, G., Wierda, W., Sasaki, K., Short, N. J., Ravandi, F., Kadia, T., Patel, K., Luthra, R., Ferrajoli, A., Garcia-Manero, G., Rios, M. B., Dellasala, S., Jabbour, E. & Cortes, J. E., Nov 9 2017, In : Blood. 130, 19, p. 2084-2091 8 p.

Research output: Contribution to journalArticle

Open Access
16 Scopus citations
2018

Integrative genomic analysis of adult mixed phenotype acute leukemia delineates lineage associated molecular subtypes

Takahashi, K., Wang, F., Morita, K., Yan, Y., Hu, P., Zhao, P., Zhar, A. A., Wu, C. J., Gumbs, C., Little, L., Tippen, S., Thornton, R., Coyle, M., Mendoza, M., Thompson, E., Zhang, J., Dinardo, C. D., Jain, N., Ravandi, F., Cortes, J. E. & 10 others, Garcia-Manero, G., Kornblau, S., Andreeff, M., Jabbour, E., Bueso-Ramos, C., Takaori-Kondo, A., Konopleva, M., Patel, K., Kantarjian, H. & Futreal, P. A., Dec 1 2018, In : Nature communications. 9, 1, 2670.

Research output: Contribution to journalArticle

Open Access
14 Scopus citations
2017

Clinical characteristics of Philadelphia positive T-cell lymphoid leukemias—(De novo and blast phase CML)

Jain, P., Kantarjian, H., Jabbour, E., Kanagal-Shamanna, R., Patel, K., Pierce, S., Garcia-Manero, G., Borthakur, G., Ravandi, F., O'Brien, S. & Cortes, J., Jan 1 2017, In : American Journal of Hematology. 92, 1, p. E3-E4

Research output: Contribution to journalLetter

6 Scopus citations
2016

Protein profiling identifies mTOR pathway modulation and cytostatic effects of Pim kinase inhibitor, AZD1208, in acute myeloid leukemia

Chen, L. S., Yang, J. Y., Liang, H., Cortes, J. E. & Gandhi, V., Dec 1 2016, In : Leukemia and Lymphoma. 57, 12, p. 2863-2873 11 p.

Research output: Contribution to journalArticle

13 Scopus citations
2017

Characteristics, outcomes, prognostic factors and treatment of patients with T-cell prolymphocytic leukemia (T-PLL)

Jain, P., Aoki, E., Keating, M., Wierda, W. G., O'Brien, S., Gonzalez, G. N., Ferrajoli, A., Jain, N., Thompson, P. A., Jabbour, E., Kanagal-Shamanna, R., Pierce, S., Alousi, A., Hosing, C., Khouri, I., Estrov, Z., Cortes, J., Kantarjian, H., Ravandi, F. & Kadia, T. M., Jul 1 2017, In : Annals of oncology : official journal of the European Society for Medical Oncology. 28, 7, p. 1554-1559 6 p.

Research output: Contribution to journalArticle

Open Access
15 Scopus citations

Sepsis and Acute Myeloid Leukemia: A Population-Level Study of Comparative Outcomes of Patients Discharged From Texas Hospitals

Malik, I. A., Cardenas-Turanzas, M., Gaeta, S., Borthakur, G., Price, K., Cortes, J. & Nates, J. L., Dec 2017, In : Clinical Lymphoma, Myeloma and Leukemia. 17, 12, p. e27-e32

Research output: Contribution to journalArticle

2 Scopus citations
2019

Outcomes of patients with chronic phase chronic myeloid leukemia (CML-CP) after discontinuation of frontline ponatinib therapy

Boddu, P., Jain, P., Borthakur, G., Verstovsek, S., Garcia-Manero, G., Daver, N., Kadia, T., Ravandi, F., Jabbour, E., Cortes, J. & Kantarjian, H., Nov 10 2019, In : Leukemia and Lymphoma. 60, 13, p. 3172-3180 9 p.

Research output: Contribution to journalArticle

1 Scopus citations
2017

A Phase II Study of Arginine Deiminase (ADI-PEG20) in Relapsed/Refractory or Poor-Risk Acute Myeloid Leukemia Patients

Tsai, H. J., Jiang, S. S., Hung, W. C., Borthakur, G., Lin, S. F., Pemmaraju, N., Jabbour, E., Bomalaski, J. S., Chen, Y. P., Hsiao, H. H., Wang, M. C., Kuo, C. Y., Chang, H., Yeh, S. P., Cortes, J., Chen, L. T. & Chen, T. Y., Dec 1 2017, In : Scientific reports. 7, 1, 11253.

Research output: Contribution to journalArticle

Open Access
21 Scopus citations

Selective inhibition of FLT3 by gilteritinib in relapsed or refractory acute myeloid leukaemia: a multicentre, first-in-human, open-label, phase 1–2 study

Perl, A. E., Altman, J. K., Cortes, J., Smith, C., Litzow, M., Baer, M. R., Claxton, D., Erba, H. P., Gill, S., Goldberg, S., Jurcic, J. G., Larson, R. A., Liu, C., Ritchie, E., Schiller, G., Spira, A. I., Strickland, S. A., Tibes, R., Ustun, C., Wang, E. S. & 6 others, Stuart, R., Röllig, C., Neubauer, A., Martinelli, G., Bahceci, E. & Levis, M., Aug 2017, In : The Lancet Oncology. 18, 8, p. 1061-1075 15 p.

Research output: Contribution to journalArticle

178 Scopus citations
2016

Prognostic impact of persistent cytogenetic abnormalities at complete remission in adult patients with acute lymphoblastic leukemia

Short, N. J., Kantarjian, H. M., Jabbour, E. J., O'Brien, S. M., Faderl, S., Burger, J. A., Garris, R., Qiao, W., Huang, X., Jain, N., Konopleva, M., Kadia, T. M., Daver, N., Borthakur, G., Cortes, J. E. & Ravandi, F., Apr 1 2016, In : American Journal of Hematology. 91, 4, p. 385-389 5 p.

Research output: Contribution to journalArticle

Open Access
2 Scopus citations

Peripheral blood blast clearance is an independent prognostic factor for survival and response to acute myeloid leukemia induction chemotherapy

Short, N. J., Benton, C. B., Chen, H. C., Qiu, P., Gu, L., Pierce, S., Brandt, M., Maiti, A., Min, T. L., Naqvi, K., Quintas-Cardama, A., Konopleva, M., Kadia, T., Cortes, J., Garcia-Manero, G., Ravandi, F., Jabbour, E., Kantarjian, H. & Andreeff, M., Dec 1 2016, In : American Journal of Hematology. 91, 12, p. 1221-1226 6 p.

Research output: Contribution to journalArticle

8 Scopus citations
2017

Buparlisib, a PI3K inhibitor, demonstrates acceptable tolerability and preliminary activity in a phase I trial of patients with advanced leukemias

Ragon, B. K., Kantarjian, H., Jabbour, E., Ravandi, F., Cortes, J., Borthakur, G., DeBose, L. K., Zeng, Z., Schneider, H., Pemmaraju, N., Garcia-Manero, G., Kornblau, S., Wierda, W., Burger, J., DiNardo, C. D., Andreeff, M., Konopleva, M. & Daver, N., Jan 1 2017, In : American Journal of Hematology. 92, 1, p. 7-11 5 p.

Research output: Contribution to journalArticle

21 Scopus citations
2018

Outcomes of Patients With Relapsed Core Binding Factor-Positive Acute Myeloid Leukemia

Khan, M., Cortes, J., Qiao, W., Alzubaidi, M. A., Pierce, S. A., Ravandi, F., Kantarjian, H. M. & Borthakur, G., Jan 2018, In : Clinical Lymphoma, Myeloma and Leukemia. 18, 1, p. e19-e25

Research output: Contribution to journalArticle

1 Scopus citations
2016

A two-stage approach for dynamic prediction of time-to-event distributions

Huang, X., Yan, F., Ning, J., Feng, Z., Choi, S. & Cortes, J., Jun 15 2016, In : Statistics in Medicine. 35, 13, p. 2167-2182 16 p.

Research output: Contribution to journalArticle

10 Scopus citations
2019
11 Scopus citations
2016

Hyper-CVAD plus ponatinib versus hyper-CVAD plus dasatinib as frontline therapy for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: A propensity score analysis

Sasaki, K., Jabbour, E. J., Ravandi, F., Short, N. J., Thomas, D. A., Garcia-Manero, G., Daver, N. G., Kadia, T. M., Konopleva, M. Y., Jain, N., Issa, G. C., Jeanis, V., Moore, H. G., Garris, R. S., Pemmaraju, N., Cortes, J. E., O'Brien, S. M. & Kantarjian, H. M., Dec 1 2016, In : Cancer. 122, 23, p. 3650-3656 7 p.

Research output: Contribution to journalArticle

61 Scopus citations